Answers are grounded in this paper and cite their sources.
Staphylococcus aureus is an important infection in chronic skin wounds, where biofilm formation and antibiotic resistance render closure significantly more difficult and create an urgent demand for non-antibiotic options. Antimicrobial photodynamic therapy (aPDT) relies on a photochemical reaction involving a photosensitizer, light of the correct wavelength and molecular oxygen in the tissue, generating reactive oxygen species (ROS) that attack bacterial membranes, nucleic acids and proteins at multiple sites at the same time. This method is active against both planktonic organisms and biofilms, is unlikely to select for resistance, and can also regulate the local inflammatory milieu of the wound so as to favor tissue regeneration, making it an intriguing choice in refractory S. aureus-associated skin wounds. The clinical dilemma faced by S. aureus, the molecular foundation of aPDT, its current clinical use, the available information on efficacy and safety, and the obstacles that still need to be overcome are discussed in this review. We discuss the practical limitations encountered to date, hypoxia within the wound bed, which constrains the photodynamic effect, incomplete penetration of biofilm and the absence of agreed treatment parameters, and consider photosensitizer modification, combination strategies and the prospects for clinical translation, to support the more standardized use of aPDT in refractory infected skin wounds.
No takes yet. Share an insight, caveat, or question.
Yu Tang (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: